58 results
8-K
CHRS
Coherus BioSciences, Inc.
13 Sep 24
Regulation FD Disclosure
5:15pm
that these actions will collectively reduce the production cost of UDENYCA by approximately one-third from current levels.
The Company reconfirms 2024 R&D … third quarter 2024 earnings announcement. The Company today reaffirmed its previous guidance for combined R&D and SG&A expenses for 2024, which
8-K
EX-99.1
CHRS
Coherus BioSciences, Inc.
8 Aug 24
Coherus BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update
4:23pm
quarter of 2024, due to the CIMERLI divestiture on March 1, 2024.
Research and development (R&D) expenses were $22.0 million and $23.3 million … as of June 30, 2024, compared to $117.7 million as of December 31, 2023.
2024 R&D and SG&A Expense Guidance
Coherus projects combined R&D and SG
8-K
EX-99.1
CHRS
Coherus BioSciences, Inc.
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
by higher royalty costs and an increase in product costs from the mix of products sold and the launch of new products.
Research and development (R&D) expense … $175.0 million of the total $250.0 in principal on Coherus’ 2027 Term Loans in April 2024.
2024 R&D and SG&A Expense Guidance
Coherus projects
8-K
EX-99.1
nn3moq8cl6u2m 1tq
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.1
rk158gtg j5v
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K/A
EX-99.2
da7trk1fft0w9pp3
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.1
01r9zbarrhpe9ffm
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
km5x xowyar7au2
27 Oct 23
Regulation FD Disclosure
4:19pm
8-K
EX-99.1
fj9s5c03 hx1h
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
cfipo57smz2d7
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
rcg103 d6t7rjd4
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
wyw26hjdj6z
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
jgi4qg8dwyan34bce
16 Jun 23
Business combination disclosure
5:17pm
425
nnwn ond3vbz
16 Jun 23
Business combination disclosure
5:14pm
425
gbd2hvuy2
16 Jun 23
Business combination disclosure
5:14pm
425
35o2by8wen
16 Jun 23
Business combination disclosure
5:12pm
425
8x4t9r ug4vm
16 Jun 23
Business combination disclosure
5:11pm